Neue Aspekte in der Diagnostik der HCV-Infektion bei Hämophilen
Maureen M. Jonas(Boston Children's Hospital), B. Matz(University of Bonn), Ulrich Spengler(University of Bonn), R. Simmonds, H.H. Brackmann, Johannes Oldenburg(University Hospital Bonn), R. Kaiser(Boehringer Ingelheim (Germany)), Achim Schneider(Gynecologic Oncology Group), Martin Lechmann(Roche (Switzerland)), K. E. Schneweis, Bettina Kochan
Cited by 0
Related Papers
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
|The Lancet Oncology|2014|948
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Naturally occurring dominant resistance mutations to hepatitis C virus protease and polymerase inhibitors in treatment-naïve patients
|Hepatology|2008|345
Hepatitis B virus infection in children and adolescents
|The Lancet. Gastroenterology & hepatology|2019|258
The HLA-A2 Restricted T Cell Epitope HCV Core35–44 Stabilizes HLA-E Expression and Inhibits Cytolysis Mediated by Natural Killer Cells
|American Journal Of Pathology|2005|171